(Special Report) Our Best Pick of 2012

Dear INO subscriber,

I've got a hot little stock tip for you.

Listen to this: My team of analysts and I just finished
strategizing how we're going to play (what we believe
might be) our best pick of 2012.

This tiny biotech out of New York is about to soar by
almost 1,000% or more.

I hardly ever get emotional about the stocks I pick. But
this one looks like a doozie.

Let me tell you why:

In 2009, a team of specialists at the Cedars-Sinai Heart
Institute in Los Angeles completed the world's first
cardiac stem cell infusion.

Then...

In late 2011, scientists from Cedars-Sinai Heart Institute
and Johns Hopkins University, reported yet another medical
milestone.

Which has never happened before. Such discoveries are taking
the medical world by storm.

And acting as catalysts for one small biotech to see record-
breaking spikes in its stock price in 2012.

Here's what I'm fairly certain about:

• Scientific breakthroughs in the biotech industry will send
  the stock of a certain tiny biotech company to all-time
  highs.
  
  
• I've been tracking this company for months. All the
  indicators point to a coming surge in its stock price due to
  a number of factor I discuss in a Special Opportunity Bulletin.
  
  
• Investor interest in stem cell technology is climbing. Soon
  to cause a buying frenzy. I'll share with you what is
  sparking the action.
  
  
• A recent medical miracle said to beat the number one disease
  killing Americans is also putting the media spotlight on
  stem cell applications for treating disease.
  
  
• The Catholic Church supports this company's efforts. The
  Vatican has given its blessing for this industry leader to
  pursue stem cell research.
  
  
• Company insiders at this biotech all of a sudden bought
  2,000% MORE shares recently than ever before. A surefire
  sign something big is about to go down.
  
  
• My team of analysts and I have already figured out a
  strategy to play this pick (plus several dozen more
  potential winners) and I'll let you know how to access our
  trading strategy.

Anyway, all of the above is included in my Special Opportunity
Bulletin .

I also mention a few other important things on this web page
you'll want to know about if you're an active investor
looking for truly spectacular opportunities.

Things happen fast in the biotech industry.

I encourage you to read this online report today because it
will not be available for long.

Sincerely,

Andrew Foster
Chief Investment Officer